Photo: NPR
AstraZeneca Sells $2.2 Billion Worth COVID-19 Vaccines: Report
Drugmaker AstraZeneca reported that it sold more than $2.2 billion worth of COVID-19 vaccines in the past nine months. Earlier, the company promised to provide jabs on a not-for-profit basis through the pandemic. However, the company is expecting to progressively transition the vaccine to 'profitability'. AstraZeneca also reported that it will be creating more vaccine units under its plans for the future of the Pandemic.
Tags: Covid-19, astrazenca, Coronavirus Vaccines, England, Vaccine Sale
Courtesy: The Guardian
Photo: Al Jazeera
Pfizer And AstraZeneca Prove To Be More Than 90% Effective Against Delta Variant
Analysis of the Public Health England stated that Pfizer is 96% effective and AstraZeneca is 92% effective against hospitalisation from the Delta variant of COVID-19 on June 14. They also stated the necessity of getting the second dose on time for the complete effectiveness of the vaccines. These percentages are comparable with vaccine effectiveness against hospitalisation from the Alpha variant, which was first identified in the UK.
Tags: Pfizer-BioNTech, astrazenca, Delta, Alpha 1, Indian COVID-19 variant, Covid-19 Vaccine
Courtesy: The Economic Times
Photo: DNA India
Oxford-AstraZeneca COVID-19 Vaccine Trials Resume in UK
Oxford University on September 12 confirmed that the trials of the COVID-19 vaccine, which is being developed in collaboration with AstraZeneca, has been resumed in UK. The university stated, "Following the recommendations of both the independent safety review committee and the UK regulator, trials will recommence." The vaccine is now in phase-3 trials and was halted on September 8 owing to an adverse reaction in one of the participants.
Tags: health care, Coronavirus Vaccines, Oxford University, astrazenca
Courtesy: The Economic Times
Photo: CNN
8,000 Jumbo Jets Required to Deliver COVID Vaccine to 7.8 Billion: IATA
Approximately 8,000 jumbo-jets will be needed to deliver Coronavirus vaccine, warned International Air Transport Association (IATA). Alerting it to be the biggest challenge aviation industry has faced, IATA asked governments to plan their logistics chain for swift movement of vaccines. Vaccines storage will also require specific temperature, hence not all planes would be suited to carry them. IATA further stated that some operators have… read-more
Tags: Coronavirus Vaccines, Supply chain , astrazenca, Covid-19, Covid-19 Vaccine
Courtesy: The Guardian
Photo: The Indian Express
Oxford-AstraZeneca Coronavirus Vaccine's Trials Shelved Citing Safety Review
The trials of the coronavirus vaccine, developed by AstraZeneca and Oxford University, has been shelved as one of the participants showed an adverse reaction. However, AstraZeneca spokesperson said, "Standard review process triggered a pause to vaccination to allow review of safety data." However, the details regarding the adverse effect have not been revealed. The trials are in the final stage, and are being conducted in various countries… read-more
Tags: Coronavirus, Coronavirus Vaccines, Oxford University, astrazenca
Courtesy: The Hindu
